Navigation Links
InspireMD Boosts MGuard Production Capacity
Date:3/2/2011

TEL AVIV, Israel, March 2, 2011 /PRNewswire/ --

InspireMD, developer of the MGuard™ net protective stent system, has expanded its MGuard production facilities to meet the steady increase in demand.  The driving forces behind the accelerating demand for MGuard include the recent recommendation of the European Society of Cardiology (ESC) mesh-based protection to be considered for PCI of highly thrombotic or SVG lesions. Currently, this type of approved mesh technology is exclusively produced by InspireMD in its unique MGuard™ mesh protected coronary stent system.  Greater awareness of the MGuard solution among interventional cardiologists worldwide has been contributing to increased MGuard sales. To accommodate this increased demand, InspireMD has enlarged its production workforce and invested in new crimping machinery that can double InspireMD's previous production capacity.

"Based on our last published financial results, for the nine months ended September 30, 2010, our sales have increased more than 100% compared to the same period in 2009, and with this growth in mind, we have expanded to meet increased production demand," said Eli Bar, CTO and VP R&D at InspireMD. "When we evaluated the success criteria for our investment in advanced crimping machinery, it was important to us that we would be able to increase production capacity by a factor of two. With our expanded facilities, we have experienced an even larger increase of our production capacity, and we are able to achieve constant output of a homogenous product of optimal quality."

"One of the main success factors of our business is our ability to produce and deliver our high quality products to match demand," stated Ofir Paz, CEO of InspireMD. "We are very pleased to see that our MGuard solution is becoming widely accepted as the preferred alternative for thrombus management in heart attack patients. The current expansion is the beginning of a major expansion in our production designed to meet the continued upward demand for MGuard solutions worldwide."

About MGuard™ CoronaryMGuard™ presents a novel combination of a coronary stent merged with an embolic protection specifically designed for Acute MI patients. The embolic protection is comprised of an ultra-thin polymer mesh sleeve that wraps the stent. The MGuard™ coronary stent provides permanent embolic protection, without affecting deliverability. MGuard™ is CE Mark approved. Mesh-based protection is now recommended for use in the recent Guidelines of the Task force of Myocardial Revascularization of the European Society of Cardiology (ESC). The MGuard™ innovative concept has enjoyed an enthusiastic welcome from leading interventional cardiologists around the world.

About InspireMD Ltd.InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures.Contact details:www.inspire-md.com Jonina OhayonMarketing Directorjonina@inspire-md.com +972-52-5791120
'/>"/>

SOURCE InspireMD
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
4. Prolong Pharmaceuticals Boosts Executive Team
5. Electronic Recordkeeping Boosts Patient Safety, Saves DMC More Than $5 Million - For Second Straight Year
6. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
7. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
8. DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms
9. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
10. MGuard(TM) Coronary Stent System Approved in Israel
11. Cypin Production Announces Launch of U.S./China BioPharma Conference:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., ... case series to be presented at the 2017 National ... begins today and continues through April 22. Physicians will ... , used to assess risk for acute kidney injury ... heart failure (ADHF). Elevated levels of ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of a pioneering ... , the largest Electronic Medical Records (EMR) provider in South Africa. By using ... a patient’s remote health progress, empowering the patient to take direct responsibility for their ...
(Date:4/26/2017)... FL (PRWEB) , ... April 26, 2017 , ... Miami ... anniversary as a dentist. , “I could have never imagined back in 1991 that ... personally,” said Dr. Gallardo. , Over the last 25 years, Dr. Gallardo has pioneered ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... for sponsors and CROs to speed clinical development, has released the industry’s ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... agreement to be the preferred physical therapy provider for Derby City CrossFit, effective ... Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
Breaking Medicine News(10 mins):